ORAL PHARMACEUTICAL DISPERSION COMPOSITIONS

The invention provides an oral pharmaceutical composition, optionally in dose unit form, comprising a lipophilic drug substance in dispersion in a physiologically tolerable aqueous carrier, preferablyan aqueous gel, wherein said drug substance contains a functional electrostatic group having a pKa v...

Full description

Saved in:
Bibliographic Details
Main Authors SETERNES TORE, HAUG INGVILD JOHANNE, DRAGET KURT INGAR, HATTREM MAGNUS, ENGELSEN STEINAR JOHAN
Format Patent
LanguageChinese
English
Published 06.04.2018
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The invention provides an oral pharmaceutical composition, optionally in dose unit form, comprising a lipophilic drug substance in dispersion in a physiologically tolerable aqueous carrier, preferablyan aqueous gel, wherein said drug substance contains a functional electrostatic group having a pKa value of from 2 to 10, characterised in that said aqueous carrier has a pH at least 0.3 below or above said pKa value, said pH being below said pKa where said group is acidic and above said pKa where said group is basic. 本发明提供了种口服药物组合物,可选择地以剂量单位的形式,包括在生理上可耐受的含水载体内分散的亲脂性药物物质,所述含水载体优选为含水凝胶,其中所述药物物质包含具有2至10的pKa值的静电官能性基团,其特征在于所述含水载体具有低于或高于所述pKa值至少0.3的pH,当所述基团为酸性时,所述pH低于所述pKa,当所述基团为碱性时,所述pH高于所述pKa。
Bibliography:Application Number: CN201711183170